| Press Release |
|
Judges Scientific plc
("Judges Scientific", "Judges", the "Company" or the "Group")
Purchase of Ordinary Shares
Judges Scientific announces that on 8 May 2024 it acquired 654 ordinary shares of 5p each ("Ordinary Shares") at a price of 11350p per Ordinary Share. The Ordinary Shares have been immediately allocated to certain employees to satisfy awards under the Company's reward scheme.
- Ends -
| - For further information please contact:
|
|
| |
| Judges Scientific plc David Cicurel, CEO Brad Ormsby, CFO Tel: +44 (0) 20 3829 6970
| Shore Capital (Nominated Adviser & Joint Broker) Stephane Auton Harry Davies-Ball Tel: +44 (0) 20 7408 4090
| | |
| Liberum (Joint Broker) Edward Mansfield Nikhil Varghese Tel : +44 (0) 20 3100 2222
| Investec Bank plc (Joint Broker) Virginia Bull Carlton Nelson Tel: +44 (0) 207 597 4000 | | |
| Alma (Financial Public Relations) Sam Modlin Rebecca Sanders-Hewitt Joe Pederzolli Tel: +44 (0) 20 3405 0205 | | | |
Notes to editors:
Judges Scientific plc (AIM: JDG), is a group focused on acquiring and developing companies in the scientific instrument sector. The Group now consists of 23 businesses acquired since 2005.
The acquired companies are primarily UK-based with products sold worldwide to a diverse range of markets including: higher education institutions, scientific research facilities, manufacturers and regulatory authorities. The UK is a recognised centre of excellence for scientific instruments. The Group has received five Queen's Awards for innovation and export.
The Group's companies predominantly operate in global niche markets, with long term growth fundamentals and resilient margins.
Judges Scientific maintains a policy of selectively acquiring businesses that generate sustainable profits and cash. Shareholder returns are created through the reduction of debt, organic growth and dividends.
For further information, please visit www.judges.uk.com
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.